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ABSTRACT  Presumptive myoblasts from explants of chick embryo pectoral muscle proliferate, 
differentiate,  and fuse to form  multinucleate  myotubes.  One event  critical  to  multinucleate 
cell formation  is the specific  adhesion of myoblasts before  union of their membranes.  In the 
studies  reported  here five  known  inhibitors of myotube formation--trifluoperazine,  sodium 
butyrate,  chloroquine,  1,10 phenanthroline, and tunicamycin--were tested for their effect on 
the Ca++-dependent  myoblast  adhesion  step. The first four inhibitors of myotube formation 
do not perturb myoblast adhesion  but rather block fusion of aggregated cells, which suggests 
that these  agents perturb  molecular  events required  for the  union  of the  lipid  bilayers.  By 
contrast,  tunicamycin  exerts  its  effect  by  inhibiting  the  myoblast  adhesion  step, thereby 
blocking myotube formation.  The effect of tunicamycin can be blocked by a protease inhibitor, 
however, which implies that the carbohydrate residues protect the glycoproteins  from proteo- 
lytic degradation  rather than  participate  directly in cell-cell adhesion.  Whereas trypsin  treat- 
ment of myoblasts in the absence of Ca  +÷ destroys the cells' ability to exhibit Ca++-dependent 
adhesion,  the presence of Ca  ++ during trypsin  treatment inhibits  the enzyme's  effect,  which 
suggests that  myoblast  adhesion  is  mediated  by a glycoprotein(s)  that  has a conformation 
affected  by Ca  ++. Finally, myoblast adhesion is inhibited by an antiserum raised against fusion- 
competent myoblasts. The effect of the antiserum  is blocked by a fraction  from the detergent 
extract  of  pectoral  muscle  that  binds  to  immobilized  wheat  germ  agglutinin,  which  again 
suggests that glycoproteins  mediate Ca++-dependent myoblast adhesion. 
Embryonic muscle can be excised from  l l-d chicks,  enzy- 
matically  dissociated,  filtered,  and  grown  in  culture.  The 
resulting  presumptive  myoblasts  proliferate,  differentiate, 
align  in  culture, and  fuse to  form multinucleate myotubes 
that express the biochemical and morphological characteris- 
tics of muscle (4, 7; reviewed in 3, 23, 46).  This progression 
of orderly and  timed  events  is  accompanied  by  regulated 
expression of new molecules, migration of cells, adhesion of 
myoblasts, and union of cell membranes. 
To shed light on the molecular nature of the events that 
occur during the formation of multinucleate cells, investiga- 
tors have sought means to inhibit the easily recognizable event 
of myotube formation.  Several agents  and  conditions that 
have been found to block myotube formation include EDTA 
(45),  cytochalasin B (24),  lectins (13),  phospholipase C (38), 
lysolecithin (48),  exogenously added cholesterol (57), inhibi- 
tion  of endogenous cholesterol synthesis in  cells  grown  in 
lipid-depleted medium (8), and enrichment of elaidate (trans- 
oleate) in  the  cellular  membrane  (25).  More  recently five 
other agents have been added to the growing list of inhibitors 
of myotube formation: trifluoperazine (TFP)  ~  (1), an antago- 
nist of  the calcium-binding protein calmodulin (30, 36); chlor- 
oquine (28), a lysomotropic amine that inhibits the function 
of lysosomal enzymes (42) and alters the turnover of receptors 
(19,  29);  1,10 phenanthroline, a metal chelator that inhibits 
soluble metalloendoproteases in  myoblasts (9,  10); sodium 
butyrate (15),  a  short chain fatty acid that may modify the 
cell membrane; and tunicamycin (18),  an inhibitor of doli- 
chol-phosphate-mediated glycosylation of proteins at aspara- 
gine-linked sites. Taken together the results of these numerous 
inhibitor studies have led investigators to the general conclu- 
sions that calcium, proteins and glycoproteins, lipids, and the 
cytoskeleton are all somehow involved in myoblast fusion. 
J Abbreviations used in this paper: TFP, trifluoperazine; WGA, wheat 
germ agglutinin. 
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© The Rockefeller University Press . 0021-9S25/85/09/0891/07  $1.00 To understand a  cellular process as complex as myogenesis 
on a  molecular level, it is necessary to dissect it into steps that 
can be manipulated  experimentally. One such step central to 
myogenesis is  the  recognition  and  adhesion  of fusion-com- 
petent  myoblasts.  Previous  work  by  Knudsen  and  Horwitz 
(32)  showed  that  cultured  myoblasts  express  an  enhanced 
ability  to  adhere  to  one  another  in  suspension at  the  same 
time that they express an optimal ability to fuse. The adhesion 
depends on Ca ÷÷ (as does myotube  formation) and is specific 
(32).  The  existence  of  Ca÷÷-dependent  myoblast  adhesion 
and,  in  addition,  Ca÷÷-independent  adhesion  has  recently 
been  confirmed  by  the  work  of Gibralter  and  Turner  (17). 
Earlier,  Knudsen  and  Horwitz  had  shown  that  the  Ca ÷÷- 
dependent  myoblast adhesion  displays optima  for pH,  tem- 
perature,  Ca ++  concentration,  and  age  of cell  culture  that 
closely parallel  those for myotube  formation  (32).  Inhibitor 
studies by the same authors showed that some agents able to 
inhibit myotube  formation--such  as energy poisons, trypsin, 
an inhibitor of cholesterol synthesis, and inhibitors of protein 
synthesis--block myoblast adhesion, whereas other inhibitors 
of myotube  formation,  such  as  cytochalasin  B,  colchicine, 
phospholipase  C,  or enrichment  of membranes  in  elaidate, 
have  no  effect on  myoblast  adhesion  (33).  Taken  together, 
these  results  led  Knudsen  and  Horwitz  to  conclude  that  a 
separate,  distinct adhesion  event that depends  on  Ca ÷÷ and 
involves cell surface proteins precedes the fusion of myoblast 
membranes. 
The studies reported here extend our understanding  of the 
nature  of the  molecules  involved  in  the  specific,  Ca÷÷-de- 
pendent myoblast adhesion step of myogenesis. A preliminary 
report of this work has been published in abstract form (31). 
MATERIALS  AND  METHODS 
Materials:  TFP, chloroquine (diphosphate salt),  1,10 phenanthroline, 
leupeptin, and cycloheximide were purchased from Sigma Chemical  Co. (St. 
Louis,  MO).  Tunicamycin  was  from  Boehringer  Mannheim  Biochemicals 
(Indianapolis,  IN).  Sodium  butyrate  was  from  J.  T.  Baker  Chemical  Co. 
(Phillipsburg, N  J). These reagents were stored according to the manufacturer's 
instructions and dissolved  immediately before use,  except for tunicamyein, 
which was stored at -70"C as a  500/~g/ml stock solution in H20/dimetbyl 
sulfoxide,  1:1. Optimal times of addition to the culture medium and optimal 
concentrations of the agents being tested were determined experimentally to be 
those that blocked  the myotube formation initiated by adding Ca  ++ to 52-h 
EGTA-blocked  cultures  without causing  cellular  toxicity,  as determined by 
morphological  examination of the cells  by  phase-contrast  microscopy  and 
trypan blue exclusion. 
Cell Culture:  Primary cultures of pectoral muscle cells and fibroblasts 
were prepared from  1  l-d chick embryos as described (32). Myoblast  cultures 
were plated on collagen-coated  culture dishes at 6 x  106 cells/100-mm dish 
and grown  in Ca++-free Dulbecco's modified Eagle's medium supplemented 
with  10% fetal calf serum (FCS),  1% Penn-Strep and 0.5%  Fungizone (both 
from Flow Laboratories,  Inc., McLean, VA), and 5 mM HEPES at 37"C in an 
atmosphere of 90% air/10% CO2. EGTA was added to the cells at a concentra- 
tion of 200-300 uM to prevent myoblast fusion. 
Harvesting Myoblasts:  EGTA-blocked, fusion-competent  myoblasts 
were detached from the substratum 50-51  h after plating  by adding a heat- 
inactivated  antiserum  that  specifically disrupts cell-substratum  adhesion of 
myoblasts. This antiserum was raised in a rabbit against cell surface, integral 
membrane giycoproteins  involved  in cell-substratum adhesion (34) purified 
from chick  cells  by antibody affinity  chromatography using  a  monoclonal 
antibody (CSAT) that rounds and detaches myoblasts from a variety of  substrata 
but does not interfere with myoblast fusion (26, 40). A maximum effect in a 
reasonable amount of time resulted when the antiserum was added at dilutions 
of from  1:200 to  1:500 3 to 4 h before the aggregation assays. The rounded 
myoblasts were removed from the culture dish by gentle pipetting, concentrated 
by centrifugation,  and resuspended in Ca*"-free Hanks' balanced salt solution 
containing 5% glucose, 10 mM HEPES, and, when indicated,  1 mM Ca  ++. 
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Production of Rabbit Antiserum against Fusion-Competent 
Myoblasts:  EOTA-blocked  myoblasts  were harvested  52  h  after  plating 
using  the  cell-substratum,  adhesion-perturbing rabbit  antiserum  described 
above. Approximately 107 cells were washed with phosphate-buffer  saline (PBS), 
pelleted by centrifugation,  resuspended in 0.5 ml PBS, mixed l:l with either 
complete (first injection)  or incomplete Freund's adjuvant,  and injected sub- 
cutaneously in four sites in a rabbit. Four injections were given at 2-wk intervals 
before the rabbit was bled and the heat-inactivated  serum was tested for its 
effect on myoblast aggregation and myotube formation. 
Assays'for Myoblast Aggregation:  Myoblast aggregation was de- 
termined on 52-h cultures by two assays. In one assay, the cell concentration 
was adjusted to 2.5-3.0 x  105 cells/ml, and l-ml aliquots were mixed in 5-ml 
Fernbach flasks for 20  min at  37°C on  an  Adams Nutator (Clay  Adams, 
Parsippany,  N J). At this cell concentration, the clusters that formed were small 
enough to permit counting of the aggregated myoblasts.  The percentage  of 
aggregated cells was scored by counting ceils using phase-contrast microscopy 
as previously described (32). 
In the second aggregation assay, the cell concentration was adjusted to 1 x 
106 cells/ml, and 0.5-ml aliquots were mixed in wells of a 24-well Costar dish 
(Costar, Cambridge,  MA) at 37°C for 20 min on the Nutator.  At this concen- 
tration, the cells formed large clusters composed of too many cells to count by 
microscopic  observation.  Instead,  the results were recorded  by photography. 
For both assays the inhibitors, when tested, were present during the incubation 
period. 
Assay for Myoblast Fusion:  To measure myotube formation, 1-2 
mM Ca ++ was added to EGTA-blocked  cultures 50-52 h after plating,  and 
fusion was quantitated 18-20  h later as previously  described (32). To assess 
fusion of myoblasts aggregated in suspension, the cells mixed at a concentration 
of I ×  106 cells/ml for 20 min at 37"C were transferred to the wells of six-well 
Costar dishes (not collagen coated) and incubated in 2.5 ml of fresh medium 
overnight  at 37"C in either the absence or presence of the inhibitors and/or 
Ca +*  . No attempt was  made to wash  away  any  remaining cell-substratum 
adhesion-perturbing antibody.  Fusion  of cells  in  suspension,  i.e.,  myoball 
formation (33), was scored by microscopic observation using an inverted phase- 
contrast microscope and by recording  the results photographically.  Multinu- 
cleate cell formation was confirmed by exposing the cells to 0.1% trypsin and 
1 mM EDTA in PBS for 15 min at 37"C and observing under the microscope 
whether or not this treatment dispersed the cells. 
Analysis of Protein Synthesis:  Protein synthesis was measured  by 
trichloroacetic  acid (TCA) precipitation of radiolabeled  cells. 10-15 ~Ci of L- 
SH-amino acid mix (New England  Nuclear,  Boston,  MA) was added to 30-h 
EGTA-blocked cultures along with tunicamycin (0.1 #g/ml) or cycloheximide 
(5 ~g/ml). 52 h after plating the cells, the medium was removed and centrifuged 
for 10 min at  15,000 rpm in an SS 34 rotor ofa Sorvall  RC2-B centrifuge 
(DuPont Instruments, Sorvall  Biomedical  Div.,  Wilmington, DE)  to collect 
any cells that had detached from the substratum. Cold 10% TCA was added to 
the cells on the culture dish and to the few cells that were retrieved from the 
conditioned medium. The cells were scraped  from the dishes with a rubber 
policeman and washed onto a 0.45-~m  filter under vacuum.  The cells were 
collected and washed on the filters and the filters were monitored for radioac- 
tivity  using  the  premixed liquid  scintillation  solution  Formula  963  (New 
England Nuclear). 
Pectoral Muscle Extraction and Lectin Affinity Chromatog- 
raphy:  Pectoral  muscle explants dissected  from  50-100  l l-12-d  chick 
embryos or skeletal muscle fibroblasts grown in roller  bottles were extracted 
with Nonidet P-40 detergent using previously described procedures (35), except 
that the Ca ++ concentration was l mM in all buffers. The muscle extract was 
fractionated  by wheat germ agglutinin  (WGA) affinity chromatography using 
described procedures (35). When the various fractions were exposed to cells in 
an antiserum-blocking assay, the detergent was removed using Bin-Beads SM- 
2 (Bio-Rad Laboratories,  Richmond, CA) as described previously (35). 
RESULTS 
We used five known  inhibitors of myotube  formation to help 
elucidate  the  nature  of  the  molecules  responsible  for  the 
specific, Ca++-dependent adhesion of myoblasts. Initially, we 
had to determine the conditions required to block  fusion of 
EGTA-blocked  cultures (initiated by addition of Ca ++)  since 
these  were  the  myoblasts  to  be  assayed  for  their  ability  to 
aggregate in suspension. Therefore, we tested various concen- 
trations and addition times for tunicamycin, sodium butyrate, 
chloroquine, TFP, and  1,10 phenanthroline.  Consistent with 
the observations of other investigators, all five agents inhibited myotube formation (data not shown). The following concen- 
trations and times of addition (hours after plating the cells) 
were  found  to  be  the  optimal  conditions  (i.e.,  the  lowest 
effective  concentration  and  shortest  incubation  time)  for 
blocking  myotube formation initiated  by adding  1-2  mM 
Ca  ÷÷ to 50-52 h  EGTA-blocked myoblasts: chloroquine,  10 
~M,  5 h; TFP,  2 uM,  24 h; sodium butyrate, 2  mM, 24 h; 
tunicamycin, 0.1  ~g/ml, 31-34  h;  1,10  phenanthroline,  10 
~g/ml, 48 h. Unless otherwise indicated these conditions were 
then  used to assess  the effect of the  myotube inhibitors on 
myoblast aggregation. 
For aggregation assays, the cells were grown in the presence 
of EGTA  and  the  myotube inhibitors  were  added  at  the 
concentrations and times described above. Approximately 51 
h after plating, the myoblasts to be used in the aggregation 
assays were detached from the substratum using the adhesion- 
perturbing antiserum described in Materials and Methods and 
assayed for their ability to aggregate in both the absence and 
presence of Ca  ÷÷ as described in Materials and Methods. The 
antiserum used to harvest the myoblasts neither aggregated 
the cells in the absence of Ca  ÷÷ during the 20-rain incubation 
nor inhibited their aggregation in the presence of Ca  ÷÷  , even 
when  added  to the assay at a  10-fold  higher concentration 
than that used to detach the myoblasts from their substratum 
(Table I). Thus, antibody-induced agglutination of cells does 
not occur under the conditions of the assay. Harvesting the 
cells using the antiserum resulted in an essentially pure myo- 
blast population free of cell surface changes that might occur 
by detaching the cells with EDTA. Calculated from the results 
of 17 experiments, the average percentage of aggregated cells 
in the absence of Ca  ÷÷ was 16% (range, 8-28%) and that in 
the presence of Ca  ÷÷ was 55% (range, 41-69%). The variabil- 
ity from day to day is not entirely understood but is probably 
due to the condition of the cells, their precise concentration, 
and perhaps the expression of the molecules involved in cell- 
cell adhesion. In any case, the data are most easily understood 
and compared when they are expressed as a function of the 
Ca++-plus  control (i.e.,  percent aggregation in treatment di- 
vided by percent aggregation in control with Ca  ÷÷ times 100). 
Sodium butyrate, chloroquine, TFP, and 1,10 phenanthro- 
line added under conditions that blocked myotube formation 
all  had  no  effect on  Ca÷÷-dependent myoblast aggregation 
(Table  II and  Fig.  1),  implying that  their  effectiveness in 
inhibiting myotube formation is not due to a perturbation of 
the events involved in myoblast recognition and adhesion. In 
contrast,  tunicamycin prevented the  Ca+÷-dependent adhe- 
sion of the  myoblasts (Table II and Fig.  1),  which suggests 
that  this  agent  inhibits  myotube formation  by preventing 
Ca+÷-dependent myoblast adhesion. For complete inhibition, 
the tunicamycin had to be added -  18 h before the aggregation 
assay. Addition 3-5 h before the aggregation assay resulted in 
only partial  or no inhibition  of myoblast aggregation.  The 
effect of tunicamycin is not due to a  general inhibition  of 
protein synthesis during the  18-20-h incubation  since TCA 
precipitation  of cells  metabolically  radiolabeled  with  3H- 
amino acids showed little effect on protein synthesis (Table 
III). On  the  other hand,  treatment with  cycloheximide, an 
inhibitor of both protein synthesis and Ca÷+-dependent my- 
oblast adhesion (33), during the same period showed a marked 
reduction in the incorporation of 3H-amino acids into TCA- 
precipitable counts  (Table  III). Although  tunicamycin  pre- 
vents  myoblast aggregation,  its  effect can  be  inhibited  by 
simultaneous  addition  of the  protease  inhibitor  leupeptin 
TABtE  I.  Myoblast Aggregation in the Presence of the Cell- 
Substratum Adhesion-perturbing Antiserum 
Conditions of assay  %Ca++-plus control 
1 mM Ca  ++  100 
No Ca  ++  24 
No Ca  ++  , antiserum  27 
1 mM Ca  ++, antiserum  96 
51-h  EGTA-blocked,  fusion-competent  myoblasts were  harvested with  the 
cell-substratum  adhesion-perturbing antiserum  (1 : I00 dilution) as described 
in Materials and Methods. The cells  were aggregated  at a concentration  of 
2.5 x  10  s cells/ml  also as described there. The antiserum was added to the 
aggregation  assay at  a  dilution  of  1:20.  The  results  are  expressed  as  a 
percentage of aggregation  in the Ca÷+-plus control and represent the average 
of two experiments. 
(Table IV), suggesting that the carbohydrate residues protect 
the glycoproteins from proteolytic degradation. 
To determine whether or not the inhibitors that have no 
effect on myoblast aggregation block fusion ofmyoblasts after 
the cells have been aggregated in the presence of Ca  ++  , the 
myoblast clusters formed at a cell  concentration of 1 x  106 
cells/ml were incubated overnight at 37"C in the continued 
presence of the inhibitors. In the control, cells aggregated in 
the presence of  Ca  ÷÷ (and absence ofinhibitors) and incubated 
overnight in  Ca  ÷÷ fused into  large,  multinucleate  myoballs 
(Fig.  2 A) that could  not be disrupted  by treatment with  1 
mM EDTA plus 0.1% trypsin. If we omitted Ca  ÷÷ from the 
medium during the overnight incubation of  aggregates formed 
in the presence of Ca  ÷÷, no fusion occurred (Fig. 2B) and the 
cells could  be dispersed  by trypsin.  Similarly,  cells  treated 
with sodium butyrate, chloroquine, TFP, or 1,10 phenanthro- 
line and aggregated in the presence of Ca  ÷÷ failed to fuse even 
though  Ca  ÷÷ was  present  during  the  overnight  incubation 
(Fig. 2, C, E, F, and G). In contrast to the above inhibitors of 
myotube formation, tunicamycin did not appear to prevent 
the fusion of cells in small aggregates that formed during the 
aggregation assay or during  the  overnight  incubation  (Fig. 
2D). 
Because Ca  ++ plays such an important role in myogenesis, 
we further investigated its relationship to the molecules im- 
plicated in  myoblast adhesion.  Knudsen  and  Horwitz (33) 
reported  that  trypsin  treatment  in  the  absence  of Ca  ÷÷  of 
fusion-competent myoblasts destroys their ability to aggregate 
when Ca  ÷+ is restored. Here we note that if 1-10 mM Ca  ÷÷ is 
added to the cells 5 min before their treatment with trypsin, 
the effect of the enzyme is greatly diminished (Table V). This 
result suggests that a Ca*÷-initiated conformation may protect 
the adhesion molecules from the action of trypsin. 
Following a  now well  established paradigm  for studying 
adhesive events in cells (reviewed in reference 11), we raised 
an antiserum against fusion-competent myoblasts in order to 
generate  antibodies  that  bind  to  the  adhesion  molecules, 
perturb ceil-cell adhesion,  and,  therefore, act as probes for 
the  presence  of adhesion-related  molecules.  We  generated 
such an antiserum by injecting a rabbit with fusion-competent 
myoblasts harvested as described in Materials and Methods. 
The  antiserum  raised  against  myoblasts (anti-myo) blocks 
both Ca++-dependent myoblast aggregation and myotube for- 
mation (Table VI). The effect of the antiserum on myoblast 
aggregation can be blocked by a Nonidet P-40 extract of chick 
pectoral  muscle  but  not  by  an  extract  of cultured  chick 
fibroblasts containing a similar amount of protein (Table VI). 
Preliminary experiments designed  to purify the antiserum- 
blocking activity revealed that the blocking activity was en- 
KNUDSEN  MyoblastAdhesion  893 FIGURE  I  Myoblast aggregation in cultures treated 
with known inhibitors of myotube formation. EGTA- 
blocked myoblasts were harvested 51  h after plating 
and mixed at a concentration of I  x  106 cells/ml  in 
the  absence  (A)  or  presence  (B)  of  I  mM  Ca  ++  at 
37°C  for  20  min.  The  following  inhibitors  were 
added to the cultures  at concentrations and  times 
indicated in the legend to Table II: C, sodium butyr- 
ate; D, tunicamycin; E, 1,10 phenanthroline; F, TFP, 
and G, chloroquine, x  40, 
TABLE II.  Quantitation of Ca++-dependent Myoblast Aggregation in 
Cultures Treated with Known Inhibitors of Myotube Formation 
%Ca++-plus 
Treatment of cells  control 
1 mM Ca  ++  100 
No Ca  ++  29 
Chloroquine, 1 mM Ca  ++  87 
TFP,  1 mM Ca  ++  93 
1,10 Phenanthroline, 1 mM Ca  ++  93 
Sodium butyrate, 1 mM Ca  ++  100 
Tunicamycin,  1 mM Ca  ++  18 
EGTA-blocked  myoblasts were  harvested 51  h after plating as described  in 
Materials and  Methods and  mixed at a concentration  of 2.5 x  10  s cells/ml 
for 20 min  at  37"C.  Inhibitors were added at the following concentrations 
and  hours  after  plating:  chloroquine,  10  /~M  at  5  h;  TFP,  2  uM at  24  h; 
tunicamycin,  0.1  /~g]ml at 31-34 h;  1,10  phenanthroline,  10 u.g/ml  at 48 h. 
The  data  represent the average of at  least  three  experiments  and  are ex- 
pressed  as a function of percent aggregation in the presence of Ca  ++. In the 
absence of Ca  ++, the percent aggregation  in the presence  of the inhibitors 
was similar  to that of the Ca++-minus  control. 
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riched ~ 10-fold by lectin affinity chromatography using im- 
mobilized  wheat  germ  agglutinin.  This  result  is  consistent 
with the  hypothesis that the  molecules that  mediate Ca  ÷÷- 
dependent myoblast adhesion are cell  surface glycoproteins. 
Further purification of these glycoproteins is in progress. 
DISCUSSION 
Over the past years, investigators studying myogenesis have 
reported a number of agents and cell culture conditions that 
inhibit the in vitro formation of multinucleate muscle cells. 
These  inhibitor  studies  have  helped  to  define  the  events 
leading  to  myotube  formation  and  to  generally  implicate 
calcium (49), proteins (33), glycoproteins (18, 43), lipids (25), 
and the cytoskeleton (24) as molecules that have roles in the 
construction of multinucleate muscle cells.  The complexity 
of the process of myotube formation has made it difficult to 
identify the molecules involved and to understand when in FIGURE  2  Myoball formation.  EGTA-blocked myo- 
blasts  were  harvested 51  h after plating and mixed 
at a concentration of 1 x  106 cells/ml in the presence 
of Ca  ++ and the inhibitors that had been added to 
the cultures  at  the concentrations  and  times  indi- 
cated in the legend to Table II. The aggregates were 
then incubated overnight in the continued presence 
of  the  inhibitors  and/or  1  mM  Ca  ÷÷,  except  in  B 
where  Ca  ++  was  omitted.  A,  no  inhibitor;  B,  no 
inhibitor (no Ca+*); C,  sodium butyrate;  D,  tunica- 
mycin; E, 1,10 phenanthroline; F, TFP; and G, chlor- 
oquine, x  40. 
TABLE 111.  Metabolically  Incorporated  TCA-precipitable 
Radioactivity in Tunicamycin-treated Cells 
Treatment of cells  cpm  %  Control 
Control  3,786 (7,022)  100 (100) 
Tunicamycin (0.1 /~g/ml)  3,351  (6,447)  88  (92) 
Cycloheximide (5 ,~g/ml)  1,056 (2,157)  28  (31) 
Reagents were added to EGTA-b|ocked cultures 31-32  h after plating and 
3H-amino acid  incorporation  was  assayed as  described  in  Materials and 
Methods. Numbers in parentheses  express the results of a duplicate experi- 
ment. 
the process of myogenesis they are synthesized and used. The 
mechanism  by which calcium  promotes  myoblast  fusion is 
unknown,  as  is  the exact  function  of the  cytoskeleton.  By 
focusing on the myoblast recognition/adhesion step of myo- 
genesis,  it is possible to refine the existing molecular infor- 
mation provided by reagents known to inhibit myotube for- 
mation and to begin to understand myogenesis at a molecular 
level. 
TABLE IV.  Effect  of the Protease Inhibitor Leupeptin on 
Tunicamycin Inhibition  of Myoblast Aggregation 
%Ca+÷-plus 
Conditions of assay  control 
1  mM  Ca ++  100 
No Ca  ++  40 
Tunicamycin, no Ca  ++  27 
Tunicamycin, 1 mM Ca  *+  50 
Leupeptin, no Ca  ++  61 
Leupeptin, 1 mM Ca  ++  91 
Tunicamycin, leupeptin, no Ca  ++  47 
Tunicamycin, leupeptin, 1 mM Ca  ++  105 
Tunicamycin (0.075/~g/ml) and leupeptin (50/~M) were added 31-32 h after 
plating and were present during the aggregation  assay.  51 h after plating the 
myoblasts were  harvested and aggregated under  the above conditions  as 
described in Materials and Methods. At higher concentrations of tunicamycin 
the leupeptin was less  effective at protecting against  the effect of tunicamycin 
on myoblast aggregation.  The high percentage of aggregation in the presence 
of leupeptin and absence of Ca  ~'÷ was observed repeatedly and may mean 
that leupeptin  protects Ca++-independent aggregation against endogenous 
protease activity. 
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Ca  ÷+ on Ca++-dependent Myoblast Aggregation 
Treatment  %Ca++-plus control 
1 mM Ca  ++  100 
0.01% trypsin,  ]  mM  FGTA  2 
0.01% trypsin,  1 mM Ca  ++  62 
0.01% trypsin,  10 mM Ca  ÷+  88 
Cells  were harvested as described  in Materials and Methods and incubated 
for  5  min  at  room  temperature  in  the  presence  of Ca  ++ or  EGTA  before 
incubation with trypsin at 37°C for 10 min, The reaction was stopped with 
excess  soybean  trypsin  inhibitor,  and  the  cells  were  aggregated  in  the 
presence of Ca  ++ as described in Materials and Methods. 
TABLE VI.  Effect  of the Antiserum  Raised against Fusion-competent 




Conditions  Aggregation  formation 
Ca  ++  100  100 
No Ca  ++  26  9 
Ca  ++, anti-myo  47  30 
Ca  ++, anti-myo,  muscle extract  93  -- 
Ca  ++, anti-myo, fibroblast extract  52  -- 
Ca  ++, anti-myo,  WGA-minus  material  42  -- 
Ca  ++, anti-myo,  WGA-plt~  material  92  -- 
For the aggregation  assays, EGTA-blocked  myoblasts were harvested ~51  h 
after plating and mixed in suspension  as described in Materials and Methods. 
The Ca  ++ concentration in all cases was 1 mM. The antiserum dilution varied 
between 1:30 and  1:40. The protein concentration of muscle  and fibroblast 
extract and material  not bound to WGA,  prepared as described in Materials 
and Methods, was 2-4 mg/ml, and that of the material  that bound to WGA 
was 0.2-0.4 mg/ml. Myotube formation was measured 20 h after the addition 
of Ca  ++ and a 1:20 dilution of anti-myo to 48-h EGTA-blocked cultures. The 
extent of both  aggregation and  fusion  are expressed  as a function  of that 
observed in the presence  of Ca  ++  . The aggregation  data represent the average 
of 2-10 experiments, and myotube formation data are from a single  experi- 
ment. Preimmune serum had no effect on myoblast aggregation  or myotube 
formation. 
Of the five inhibitors of myotube formation tested, only 
tunicamycin blocks the specific, Ca÷*-dependent aggregation 
of fusion-competent myoblasts. This occurs at concentrations 
that have no effect on overall protein synthesis, even though 
to block myoblast aggregation totally the inhibitor has to be 
added ~ 18 h before the assay. Since addition of tunicamycin 
1-5 h before the assay results in only a slight inhibition, we 
postulate that the adhesion glycoproteins are being synthe- 
sized -34 h after plating the cells and that their expression is 
maximal a few hours before the EGTA-blocked myoblasts as 
a population display an optimal ability to adhere and fuse 
(i.e., 52 h after plating in low Ca÷+). 
The studies reported here indicate that the myotube inhib- 
itors sodium butyrate, chloroquine, TFP, and  1,10 phenan- 
throline do not exert their effect by preventing the specific 
adhesion of fusion-competent myoblasts. This conclusion is 
based on the observation that the inhibitors, when added to 
cultures at times and concentrations known to block myotube 
formation, do not block the Ca÷÷-dependent aggregation of 
myoblasts in suspension. These results suggest, for example, 
that  neither  metalloendoproteases nor  calmodulin-binding 
proteins are involved in Ca+÷-dependent myoblast adhesion. 
Rather, all four inhibitors block the fusion of the myoblasts 
after their adhesion in the presence of Ca  ++  . The mechanisms 
of action  of these  agents  remain  speculative and  are best 
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expressed by the authors who first noted their ability to inhibit 
myotube formation (1, 9, 10,  15, 28). 
Simultaneous addition of a protease inhibitor, leupeptin, 
blocks the effect oftunicamycin on Ca++-dependent myoblast 
aggregation,  which implies, as others have reported (44), that 
the carbohydrate residues do not participate in the adhesion 
event, but  rather that they protect the glycoproteins from 
proteolytic degradation. This is consistent with the previous 
observation  of Knudsen  and  Horwitz  (33)  that  myoblast 
adhesion is not perturbed by treatment of cells with agents 
known  to  perturb carbohydrate residues such  as  galactose 
oxidase, mixed glycosidases, and neuraminidase. 
Since myoblast aggregation is  inhibited by treating cells 
with trypsin in the absence of Ca  ÷÷  , it seems likely that the 
protein portion of the glycoprotein(s) is involved in the spe- 
cific adhesion of the myoblasts. It is possible  that the glyco- 
protein has a Ca++-dependent conformation, since the pres- 
ence of Ca  ÷÷ appears to protect the adhesion molecules from 
degradation by trypsin. Such a Ca++-dependent conformation 
has  been  reported  for  uvomorulin,  the  cell-cell adhesion 
molecule involved in early mouse embryogenesis (27). 
Together with  previous observations, the  data presented 
here suggest that a distinct Ca++-dependent recognition/adhe- 
sion event involving surface membrane glycoproteins is nec- 
essary, but not sufficient, for myoblast fusion. Molecules that 
mediate Ca÷+-dependent adhesion have been implicated in 
interactions of lung cells (51),  fibroblasts (56),  neural retina 
cells (6, 20-22, 37, 53-55), liver cells (2, 5, 16, 41), teratocar- 
cinoma cells (41, 52, 58, 59), epithelial cells (12), and in early 
embryogenesis (11,  14, 27, 47, 50). Myoblast adhesion differs 
from that in other cells, however, because it is accompanied 
by cell fusion. As Neff et al. (39) showed, membrane conti- 
guity is apparent within 20-30 min after myoblast fusion is 
initiated by the addition of Ca  ÷÷ to fusion-competent myoag- 
gregates, which suggests that fusion closely follows adhesion. 
Indeed, it may be that Ca+÷-dependent adhesion triggers  a 
cascade of events that results in the formation of multinu- 
cleate muscle. 
In summary, an essential step in myogenesis includes the 
specific  interaction  of myoblasts before their  fusion.  This 
event requires Ca  ÷+ and appears to be mediated by cell surface 
glycoproteins that may have a Ca++-dependent conformation. 
After adhesion, the membranes between adjacent cells unite 
by a process that appears to require a particular lipid com- 
position, the continued presence of Ca  ÷+, and the cytoskel- 
eton. These events may be initiated by Ca++-dependent my- 
oblast interaction and may result from a cascade of events 
triggered by surface glycoproteins that effect cell-cell adhe- 
sion. 
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